Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
+$19.8M |
| 2 |
WFT
Weatherford International plc
WFT
|
+$15.3M |
| 3 |
ICL Group
ICL
|
+$11.4M |
| 4 |
Liberty Media Series C
FWONK
|
+$9.02M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$6.93M |
Top Sells
| 1 |
Apple
AAPL
|
+$24.3M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$23.5M |
| 3 |
Exxon Mobil
XOM
|
+$10.5M |
| 4 |
IBM
IBM
|
+$8.85M |
| 5 |
HSH
HILLSHIRE BRANDS CO
HSH
|
+$8.67M |
Sector Composition
| 1 | Healthcare | 13.81% |
| 2 | Technology | 13.81% |
| 3 | Energy | 11.49% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Staples | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Regis Corp
RGS
$70M
| $1.03M | ﹤0.01% |
3,220
-65
| -2% | -$20.8K |
|
1652
Sturm, Ruger & Co
RGR
$607M
| $1.03M | ﹤0.01% |
21,100
-400
| -2% | -$19.5K |
|
1653
Novavax
NVAX
$1.3B
| $1.02M | ﹤0.01% |
12,273
-275
| -2% | -$22.9K |
|
|
LORL
1654
DELISTED
Loral Space and Communications, Inc.
LORL
| $1.02M | ﹤0.01% |
14,200
-300
| -2% | -$21.5K |
|
1655
First Financial Bancorp
FFBC
$2.47B
| $1.02M | ﹤0.01% |
64,300
-1,200
| -2% | -$19K |
|
1656
Insight Enterprises
NSIT
$3.91B
| $1.02M | ﹤0.01% |
45,000
-2,100
| -4% | -$47.5K |
|
|
LTXB
1657
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $1.02M | ﹤0.01% |
42,500
-800
| -2% | -$19.1K |
|
|
HW
1658
DELISTED
Headwaters Inc
HW
| $1.02M | ﹤0.01% |
81,100
-1,400
| -2% | -$17.6K |
|
1659
CSG Systems International
CSGS
$1.87B
| $1.01M | ﹤0.01% |
38,500
-600
| -2% | -$15.8K |
|
1660
NBT Bancorp
NBTB
$2.28B
| $1.01M | ﹤0.01% |
44,900
-900
| -2% | -$20.3K |
|
1661
ESCO Technologies
ESE
$5.39B
| $1.01M | ﹤0.01% |
29,000
-500
| -2% | -$17.4K |
|
|
MHR
1662
DELISTED
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
| $1.01M | ﹤0.01% |
180,900
| – | – |
|
|
IRC
1663
DELISTED
INLAND REAL ESTATE CORP
IRC
| $1.01M | ﹤0.01% |
101,600
-2,100
| -2% | -$20.8K |
|
|
ARNA
1664
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1M | ﹤0.01% |
23,970
-410
| -2% | -$17.2K |
|
1665
Cato Corp
CATO
$89.8M
| $1M | ﹤0.01% |
29,100
+2,300
| +9% | +$79.3K |
|
1666
Provident Financial Services
PFS
$2.61B
| $1M | ﹤0.01% |
61,300
-1,000
| -2% | -$16.4K |
|
1667
Diodes
DIOD
$2.47B
| $1M | ﹤0.01% |
41,800
-700
| -2% | -$16.7K |
|
1668
Otter Tail
OTTR
$3.49B
| $1M | ﹤0.01% |
37,500
-600
| -2% | -$16K |
|
1669
Globus Medical
GMED
$7.99B
| $999K | ﹤0.01% |
50,800
| – | – |
|
|
IMGN
1670
DELISTED
Immunogen Inc
IMGN
| $998K | ﹤0.01% |
94,200
-1,600
| -2% | -$17K |
|
|
BDBD
1671
DELISTED
BOULDER BRANDS INC
BDBD
| $988K | ﹤0.01% |
72,500
| – | – |
|
|
INN
1672
Summit Hotel Properties
INN
$625M
| $987K | ﹤0.01% |
91,600
-1,700
| -2% | -$18.3K |
|
1673
Intrepid Potash
IPI
$387M
| $987K | ﹤0.01% |
6,390
-110
| -2% | -$17K |
|
|
MOVE
1674
DELISTED
MOVE INC COM STK NEW (DE)
MOVE
| $985K | ﹤0.01% |
47,000
| – | – |
|
|
MACK
1675
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $977K | ﹤0.01% |
14,146
| – | – |
|